Arcturus Therapeutics Holdings Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Arcturus Therapeutics Holdings Inc. reported Cash And Cash Equivalents At Carrying Value of $230.91 million for the year ending 2025.

  • Arcturus Therapeutics Holdings Inc. showed a decrease of -2.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Arcturus Therapeutics Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Arcturus Therapeutics Holdings Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 529.0%.
  • Historical annual values: Fiscal year 2025: $230.91 million | Fiscal year 2024: $237.03 million | Fiscal year 2023: $292.01 million | Fiscal year 2022: $391.88 million | Fiscal year 2021: $370.49 million | Fiscal year 2020: $462.90 million | Fiscal year 2019: $71.35 million | Fiscal year 2018: $36.71 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: